Key points are not available for this paper at this time.
These recommendations update for 1985-86 the information on the vaccine and antiviral agent available for control of influenza. Changes include addition of statements about the route of vaccine administration; the use of amantadine in medical personnel during influenza A outbreaks; the need to prepare contingency plans to expedite use of amantadine in aborting influenza A outbreaks among residents of institutions; and reduction in the dosage of amantadine for older patients or persons with seizure disorders.
A Tue, study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: